Pulse Biosciences (PLSE) Change in Cash (2015 - 2025)

Pulse Biosciences' Change in Cash history runs 11 years deep, the most recent figure standing at -$14.5 million for Q4 2025.

• In Q4 2025, Change in Cash fell 137.12% year-over-year to -$14.5 million; the TTM figure through Dec 2025 stood at -$37.3 million (down 150.63% YoY), while the FY2025 annual figure was -$37.3 million, down 150.63% from the prior year.
• Change in Cash for Q4 2025 stood at -$14.5 million, down from -$11.1 million in the prior quarter.
• The five-year high for Change in Cash was $54.4 million in Q3 2022, with the low at -$15.9 million in Q1 2022.
• The 5-year median for Change in Cash is -$7.5 million (2022), against an average of $3.4 million.
• Peak annual rise in Change in Cash reached 4813.99% in 2021, while the deepest fall reached 348.04% in 2021.
• Pulse Biosciences' Change in Cash stood at -$13.4 million in 2021, then jumped by 40.02% to -$8.0 million in 2022, then grew by 24.95% to -$6.0 million in 2023, then soared by 747.82% to $39.0 million in 2024, then slumped by 137.12% to -$14.5 million in 2025.
• Business Quant data shows PLSE's Change in Cash at -$14.5 million in Q4 2025, -$11.1 million in Q3 2025, and -$12.9 million in Q2 2025.